PMID: 4385052Mar 1, 1968Paper

Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase

The Journal of Pharmacy and Pharmacology
G BartholiniA Pletscher


No abstract listed.


Nov 1, 1966·Journal of Neurochemistry·E Giacalone, L Valzelli
Mar 14, 1957·Annals of the New York Academy of Sciences·S UDENFRIENDD F BOGDANSKI
Sep 15, 1962·Experientia·W P BURKARDA PLETSCHER
Sep 20, 1963·Science·A H FRIEDMANG FRIEDMAN
Aug 1, 1964·Archives of Biochemistry and Biophysics·W P BURKARDA PLETSCHER
Dec 2, 1964·Archiv für Psychiatrie und Nervenkrankheiten·W BIRKMAYER, O HORNYKIEWICZ
Dec 1, 1960·British Journal of Pharmacology and Chemotherapy·F R Domer, W Feldberg

❮ Previous
Next ❯


Jan 1, 1972·Zeitschrift für Neurologie·U K RinneT Sirtola
Jan 1, 1971·Psychopharmacologia·J MajE Mogilnicka
Jan 1, 1973·Journal of Neural Transmission·U Strömberg, B Waldeck
Jan 1, 1974·Journal of Neural Transmission·W BirkmayerP Riederer
Jan 1, 1989·Journal of Neural Transmission·A Agmo, H Fernández
Jan 1, 1980·Journal of Neural Transmission·P LavieB Sharf
Jan 1, 1972·Journal of Neural Transmission·W BirkmayerP Riederer
Jan 1, 1996·Journal of Neural Transmission·W KuhnH Przuntek
Oct 15, 1998·Journal of Molecular Neuroscience : MN·S M Mockus, K E Vrana
Aug 1, 1973·Electroencephalography and Clinical Neurophysiology·J C GillinW E Bunney
Jan 1, 1977·Electroencephalography and Clinical Neurophysiology·D C Brooks, M D Gershon
Jun 1, 1974·European Journal of Pharmacology·G PaalzowB Stalby
Aug 1, 1976·European Journal of Pharmacology·S Kafi, J M Gaillard
Jul 15, 1979·European Journal of Pharmacology·J W Commissiong, E M Sedgwick
Apr 23, 1982·European Journal of Pharmacology·C PycockC O'Shaughnessy
Aug 1, 1975·Journal of Psychiatric Research·D E RedmondJ W Maas
Oct 1, 1974·Life Sciences·O Hornykiewicz
Jul 2, 1979·Life Sciences·J W Commissiong, E M Sedgwick
Sep 1, 1971·Neuropharmacology·U G Kamat, U K Sheth
Aug 1, 1996·Pharmacology, Biochemistry, and Behavior·L MolinengoP Ghi
Feb 1, 1982·Psychiatry Research·D WoodP H Wender
Jan 1, 1983·Progress in Neurobiology·R H FishmanH L Klawans
Jan 1, 1979·Clinical Neurology and Neurosurgery·W BirkmayerB H Youdim
Jan 1, 1975·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·L K Ng, I J Kopin
Jan 1, 1975·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·G Bartholini, A Pletscher
Jan 1, 1976·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·A M Ernst
Jan 1, 1983·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·S AlgeriG Venturini

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.